Diseases
A cluster-randomized trial investigating the impact of the COPD Assessment in Primary Care To Identify Undiagnosed Respiratory Disease and Exacerbation Risk (CAPTURE) tool on primary care clinician behavior and patient outcomes has yielded surprising results. The study, conducted by researchers from the University of Massachusetts, found that while the tool
Diseases
Research published in Current Oncology suggests that immune checkpoint inhibitors (ICIs) are a common treatment option for non-small cell lung cancer (NSCLC), but may pose a risk of potentially life-threatening immune-related adverse events, including checkpoint inhibitor pneumonitis (CIP). A study conducted at the Jewish General Hospital in Montreal, Canada, examined
Diseases
A new study published in the International Journal of COPD has investigated the cost-effectiveness of a personalized early warning decision support system, COPDPredict, in predicting and preventing acute exacerbations of chronic obstructive pulmonary disease (COPD). The research, conducted by the Institute for Applied Health Research, found that COPDPredict was potentially
